Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Vbi Vaccines Inc (VBIVQ)
:VBIVQ
Holding VBIVQ?
Track your performance easily
VBIVQ Stock Chart & Stats
Day’s Range― - ―
52-Week Range<$0.01 - $1.35
Previous CloseN/A
Volume1.28K
Average Volume (3M)36.88K
Market Cap
$14.34K
Enterprise ValueN/A
Total Cash (Recent Filing)$32.28M
Total Debt (Recent Filing)$11.96M
Price to Earnings (P/E)―
Beta2.34
Next Earnings
Mar 04, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-6.92
Shares Outstanding178,257,000
10 Day Avg. Volume916
30 Day Avg. Volume36,879
Standard Deviation0.31
R-Squared0.12
Alpha-0.10
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.00
Price to Cash Flow (P/CF)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
VBI Vaccines News
PremiumCompany Announcements
VBI Vaccines Restructures and Acquired by K2 VBI TrustOwnership Overview
―
Insiders
<0.01% Other Institutional Investors
100.00% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
VBIVQ FAQ
What was Vbi Vaccines Inc’s price range in the past 12 months?
Vbi Vaccines Inc lowest stock price was <$0.01 and its highest was $1.35 in the past 12 months.
What is Vbi Vaccines Inc’s market cap?
Vbi Vaccines Inc’s market cap is $14.34K.
When is Vbi Vaccines Inc’s upcoming earnings report date?
Vbi Vaccines Inc’s upcoming earnings report date is Mar 04, 2025 which is in 41 days.
How were Vbi Vaccines Inc’s earnings last quarter?
Currently, no data Available
Is Vbi Vaccines Inc overvalued?
According to Wall Street analysts Vbi Vaccines Inc’s price is currently Overvalued.
Does Vbi Vaccines Inc pay dividends?
Vbi Vaccines Inc does not currently pay dividends.
What is Vbi Vaccines Inc’s EPS estimate?
Vbi Vaccines Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Vbi Vaccines Inc have?
Vbi Vaccines Inc has 178,257,000 shares outstanding.
What happened to Vbi Vaccines Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Vbi Vaccines Inc?
Among the largest hedge funds holding Vbi Vaccines Inc’s share is Perceptive Advisors LLC. It holds Vbi Vaccines Inc’s shares valued at 0.
---
Company Description
Vbi Vaccines Inc
VBI Vaccines, Inc. is a biopharmaceutical company. It engages in the development of eVLP vaccine platform for the design of (e) virus-like-particle vaccines that closely mimic the target virus. The company also involves in the development of thermostable technology that enables the development of vaccines and biologics that can withstand storage or shipment at constantly fluctuating temperatures. VBI Vaccines was founded on July 25, 2014 and is headquartered in Cambridge, MA.
---
Anixa Biosciences
―
Adaptimmune Therapeutics
―
CytoDyn
―
Eton Pharmaceuticals
―
GlaxoSmithKline
―
---